Overview
Viral hepatitis is inflammation of the liver caused by infection with hepatotropic viruses, principally hepatitis A, B, C, D, and E, which differ in transmission, natural history, and outcome. Hepatitis B and C in particular can establish chronic infection that progresses to fibrosis, cirrhosis, and hepatocellular carcinoma, making detection and treatment major public-health priorities. A central theme in this area is diagnosis and confirmation, including the value of confirmatory testing for hepatitis C in blood donors and laboratory approaches to screening. A second strand concerns treatment and care cascades, including high completion rates of short-course hepatitis C therapy in prison settings, tenofovir treatment of chronic hepatitis B, and outreach-based models that move drug users from screening through to cure. A third addresses prevention and burden, including occupational knowledge and practices for hepatitis B prevention among hospital staff, and hospital-based studies of chronic liver disease in which viral hepatitis is a contributor. Related work examines hepatitis C virus infection complicated by hepatocellular carcinoma. Methodologically the field combines laboratory diagnostics, treatment cohorts, and prevention studies. By clarifying how viral hepatitis is detected, treated, and prevented, research in this area supports efforts to interrupt transmission, expand access to curative therapy, and reduce the long-term liver-related consequences of infection.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Excellent Completion Rate of 8-Weeks Hepatitis C Treatment in Prison; Results of French National Study.
Treatment of Chronic Hepatitis B With Tenofovir At The University Teaching Hospital Campus of Lome (Togo)
Factors Influencing Hospital Cleaners’ Knowledge and Practices toward Hepatitis B prevention in Northern Province of Rwanda
Magnitude and Trends of Chronic Liver Disease: A Retrospective Hospital Based Study in Eastern Amhara Region, Northeast Ethiopia
Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia
Development of Municipal Decision-Making Strategies as Management Tools to Combat Waterborne Diseases
Successful Cascade of Care and Cure HCV in 5382 Drugs Users: How Increase HCV Treatment by Outreach Care, Since Screening to Treatment
Laboratory Tests Used in the Diagnosis of Immune Thrombocytopenia and General Treatment Approaches
Role of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
How this research is being cited
The 12 articles above have been cited 23 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BioMed Research International
-
2026 · Nursing Reports
-
2025 · BMC Gastroenterology
-
2025 · BMC Gastroenterology
-
2024 · Infection Prevention in Practice
-
2024 · Journal of Drugs Addiction & Therapeutics
-
2024 · Risk Management and Healthcare Policy
-
Edwin Kigozi et al. · 2024 · Infection Prevention in Practice
A sample of recent works citing this journal's research on Viral Hepatitis, linking to each citing work.